FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.The Food and Drug Administration on Thursday said the active ingredient in Eli Lilly's weight loss drug Zepbound is no longer in shortage, a decision that will eventually bar compounding pharmacies from making cheaper, unbranded versions of the injection."FDA has determined that the shortage of tirzepatide injection products, which first began in December 2022, is resolved," the agency said in a letter ...